$ROIV
Roivant Sciences Ltd.

2024 Q2 Form 10-K Financial Statement

#000114036124028145 Filed on May 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2024
Revenue $55.13M $28.93M $124.8M
YoY Change 154.96% -52.79% 103.65%
Cost Of Revenue $3.978M $4.412M $15.56M
YoY Change -5.6% -66.39% 18.53%
Gross Profit $51.15M $24.52M $109.2M
YoY Change 193.82% -49.08% 126.85%
Gross Profit Margin 92.78% 84.75% 87.53%
Selling, General & Admin $148.5M $169.6M $687.4M
YoY Change -4.91% -71.75% 14.48%
% of Gross Profit 290.34% 691.8% 629.32%
Research & Development $133.2M $120.9M $501.7M
YoY Change 6.45% -80.59% -4.47%
% of Gross Profit 260.41% 493.12% 459.32%
Depreciation & Amortization $4.883M $5.225M $22.04M
YoY Change -16.37% -12.23% 16.86%
% of Gross Profit 9.55% 21.31% 20.17%
Operating Expenses $285.7M $290.5M $1.231B
YoY Change -4.14% -76.25% -0.44%
Operating Profit -$120.2M -$266.0M $4.242B
YoY Change -56.52% -77.37% -460.92%
Interest Expense $13.40M $92.19M $34.78M
YoY Change 50.35% -655.39% 24.35%
% of Operating Profit 0.82%
Other Income/Expense, Net -$1.825M -$33.06M -$6.089M
YoY Change -139.73% -46.84% -138.52%
Pretax Income $70.15M -$191.5M $4.253B
YoY Change -121.51% -84.37% -447.27%
Income Tax $12.66M -$8.957M $22.22M
% Of Pretax Income 18.04% 0.52%
Net Earnings $95.30M -$151.1M $4.349B
YoY Change -132.66% -85.02% -531.0%
Net Earnings / Revenue 172.85% -522.35% 3484.86%
Basic Earnings Per Share $0.13 $5.55
Diluted Earnings Per Share $0.12 -$0.19 $5.23
COMMON SHARES
Basic Shares Outstanding 738.7M 805.8M 783.2M
Diluted Shares Outstanding 781.6M 831.0M

Balance Sheet

Concept 2024 Q2 2024 Q1 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.679B $6.536B $6.536B
YoY Change 295.97% 289.77% 289.77%
Cash & Equivalents $5.679B $6.536B $6.536B
Short-Term Investments
Other Short-Term Assets $323.0M $196.1M $78.06M
YoY Change 154.19% 61.05% -35.9%
Inventory $34.00M $35.25M $35.25M
Prepaid Expenses $57.28M $55.10M
Receivables $79.79M $53.55M $53.55M
Other Receivables $25.04M $29.27M $29.27M
Total Short-Term Assets $6.001B $6.732B $6.732B
YoY Change 284.43% 274.28% 274.28%
LONG-TERM ASSETS
Property, Plant & Equipment $17.84M $19.06M $65.95M
YoY Change -50.81% -51.24% -28.58%
Goodwill
YoY Change
Intangibles $136.0M $137.8M
YoY Change -6.22% -4.86%
Long-Term Investments $263.0M $247.8M $247.8M
YoY Change -11.23% -18.59% -18.59%
Other Assets $32.81M $39.11M $39.11M
YoY Change -29.15% -20.96% -20.96%
Total Long-Term Assets $494.9M $490.7M $490.7M
YoY Change -13.99% -16.98% -16.98%
TOTAL ASSETS
Total Short-Term Assets $6.001B $6.732B $6.732B
Total Long-Term Assets $494.9M $490.7M $490.7M
Total Assets $6.496B $7.222B $7.222B
YoY Change 204.05% 202.25% 202.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.74M $53.23M $53.23M
YoY Change -44.55% 40.7% 40.7%
Accrued Expenses $138.3M $175.6M $185.5M
YoY Change 15.89% 5.06% 3.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $12.00M $12.00M $12.00M
YoY Change -72.98% -70.53% -71.97%
Total Short-Term Liabilities $215.0M $266.8M $266.8M
YoY Change -12.23% -2.09% -2.09%
LONG-TERM LIABILITIES
Long-Term Debt $311.7M $430.6M $430.6M
YoY Change -19.05% 14.67% 13.59%
Other Long-Term Liabilities $1.661M $3.602M $76.60M
YoY Change -90.17% -78.85% -41.29%
Total Long-Term Liabilities $1.661M $3.602M $507.2M
YoY Change -90.17% -78.85% -0.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $215.0M $266.8M $266.8M
Total Long-Term Liabilities $1.661M $3.602M $507.2M
Total Liabilities $601.2M $774.0M $1.254B
YoY Change -25.09% -1.03% 1.79%
SHAREHOLDERS EQUITY
Retained Earnings $671.5M $576.2M
YoY Change -116.38% -115.16%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.435B $5.969B $5.969B
YoY Change
Total Liabilities & Shareholders Equity $6.496B $7.222B $7.222B
YoY Change 204.05% 202.25% 202.25%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2024
OPERATING ACTIVITIES
Net Income $95.30M -$151.1M $4.349B
YoY Change -132.66% -85.02% -531.0%
Depreciation, Depletion And Amortization $4.883M $5.225M $22.04M
YoY Change -16.37% -12.23% 16.86%
Cash From Operating Activities -$192.8M -$108.5M -$765.3M
YoY Change -22.85% -39.44% -9.26%
INVESTING ACTIVITIES
Capital Expenditures $965.0K $349.0K $1.382M
YoY Change 139.45% -78.48% -89.11%
Acquisitions
YoY Change
Other Investing Activities $0.00 $7.277M -$8.592M
YoY Change -100.0% -93.68% 1123.93%
Cash From Investing Activities -$965.0K $6.928M $5.204B
YoY Change -1019.05% -93.9% -11854.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $199.8M
YoY Change -35.95%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -660.6M -32.62M 419.4M
YoY Change -8935.31% -115.51% -16.04%
NET CHANGE
Cash From Operating Activities -192.8M -108.5M -765.3M
Cash From Investing Activities -965.0K 6.928M 5.204B
Cash From Financing Activities -660.6M -32.62M 419.4M
Net Change In Cash -857.2M -134.2M 4.858B
YoY Change 253.51% -192.65% -1372.09%
FREE CASH FLOW
Cash From Operating Activities -$192.8M -$108.5M -$765.3M
Capital Expenditures $965.0K $349.0K $1.382M
Free Cash Flow -$193.8M -$108.8M -$766.7M
YoY Change -22.59% -39.79% -10.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Local Phone Number
LocalPhoneNumber
400 3347
CY2024 dei Security12b Title
Security12bTitle
Common Shares, $0.0000000341740141 per share
CY2024 dei Trading Symbol
TradingSymbol
ROIV
CY2024 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001635088
CY2024 dei Auditor Firm
AuditorFirmId
42
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 dei Entity File Number
EntityFileNumber
001-40782
CY2024 dei Entity Registrant Name
EntityRegistrantName
ROIVANT SCIENCES LTD.
CY2024 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
D0
CY2024 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1173944
CY2024 dei Entity Address Address Line1
EntityAddressAddressLine1
7th Floor
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
50 Broadway
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
London
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
SW1H 0DB
CY2024 dei Entity Address Country
EntityAddressCountry
GB
CY2024 dei Country Region
CountryRegion
44
CY2024 dei City Area Code
CityAreaCode
207
CY2024 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Public Float
EntityPublicFloat
8000000000
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
738721807
CY2024 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2024 dei Auditor Location
AuditorLocation
Iselin, New Jersey
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6535706000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1676813000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
196122000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
121774000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
6731828000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1798587000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19058000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
39086000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
46892000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
53251000
CY2024Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
247753000
CY2023Q1 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
304317000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
137842000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
144881000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
39109000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49482000
CY2024Q1 us-gaap Assets
Assets
7222482000
CY2023Q1 us-gaap Assets
Assets
2389604000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
53225000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
37830000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
175586000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
167129000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9893000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11693000
CY2024Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
6000000
CY2023Q1 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
26940000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
12000000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
40720000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16054000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15076000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
266758000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
272448000
CY2024Q1 roiv Liability Instruments Measured At Fair Value
LiabilityInstrumentsMeasuredAtFairValue
25737000
CY2023Q1 roiv Liability Instruments Measured At Fair Value
LiabilityInstrumentsMeasuredAtFairValue
63546000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
47265000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
53476000
CY2024Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
204371000
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
180700000
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
430591000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
375515000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3602000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
17032000
CY2024Q1 us-gaap Liabilities
Liabilities
773953000
CY2023Q1 us-gaap Liabilities
Liabilities
782017000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000000341740141
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0000000341740141
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
7000000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
806677954
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
806677954
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
760143393
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
760143393
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
0
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
0
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5396492000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4933137000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
576172000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3772754000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4083000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2617000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
5968581000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1157766000
CY2024Q1 us-gaap Minority Interest
MinorityInterest
479948000
CY2023Q1 us-gaap Minority Interest
MinorityInterest
449821000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6448529000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1607587000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7222482000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2389604000
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
124795000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
61280000
CY2024 roiv Operating Costs
OperatingCosts
15560000
CY2023 roiv Operating Costs
OperatingCosts
13128000
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
501736000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
525215000
CY2024 roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
26450000
CY2023 roiv Acquired In Process Research And Development Expense
AcquiredInProcessResearchAndDevelopmentExpense
97749000
CY2024 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
687443000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
600506000
CY2024 us-gaap Operating Expenses
OperatingExpenses
1231189000
CY2023 us-gaap Operating Expenses
OperatingExpenses
1236598000
CY2024 roiv Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
5348410000
CY2023 roiv Gain Loss On Sale Of Assets
GainLossOnSaleOfAssets
0
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
4242016000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1175318000
CY2024 us-gaap Gain Loss On Investments
GainLossOnInvestments
-47973000
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
-20815000
CY2024 roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-78943000
CY2023 roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-78001000
CY2024 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
32772000
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
29276000
CY2024 roiv Interest Income
InterestIncome
146425000
CY2023 roiv Interest Income
InterestIncome
32184000
CY2024 us-gaap Interest Expense
InterestExpense
34778000
CY2023 us-gaap Interest Expense
InterestExpense
27968000
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6089000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15808000
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4253430000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1224834000
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22224000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5190000
CY2024 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4231206000
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1230024000
CY2024 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
0
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
114561000
CY2024 us-gaap Profit Loss
ProfitLoss
4231206000
CY2023 us-gaap Profit Loss
ProfitLoss
-1115463000
CY2024 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-117720000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-106433000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
4348926000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1009030000
CY2024 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
4348926000
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1123591000
CY2024 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
114561000
CY2024 us-gaap Net Income Loss
NetIncomeLoss
4348926000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1009030000
CY2024 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
5.55
CY2023 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.58
CY2024 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.16
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.55
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.42
CY2024 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
5.23
CY2023 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.58
CY2024 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2023 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.16
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.23
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.42
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
783248906
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
712791115
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
831049444
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
712791115
CY2024 us-gaap Profit Loss
ProfitLoss
4231206000
CY2023 us-gaap Profit Loss
ProfitLoss
-1115463000
CY2024 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-936000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-1490000
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-936000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1490000
CY2024 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
4230270000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1116953000
CY2024 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-117190000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-106252000
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4347460000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1010701000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2038943000
CY2023 roiv Stock Issued During Period Value Net Issuance Costs
StockIssuedDuringPeriodValueNetIssuanceCosts
311683000
CY2023 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansAndTaxWithholdingPayments
8737000
CY2023 roiv Stock Issued During Period Value Common Shares Related To Settlement Of Transaction Consideration
StockIssuedDuringPeriodValueCommonSharesRelatedToSettlementOfTransactionConsideration
0
CY2023 roiv Stock Issued During Period Common Shares And Other Consideration For Acquisition Value
StockIssuedDuringPeriodCommonSharesAndOtherConsiderationForAcquisitionValue
8948000
CY2023 roiv Issuance Of Subsidiary Common Shares To The Company And Capital Contributions To Subsidiaries
IssuanceOfSubsidiaryCommonSharesToTheCompanyAndCapitalContributionsToSubsidiaries
0
CY2023 roiv Issuance Of Subsidiary Common Shares To The Company Net Issuance Costs Value
IssuanceOfSubsidiaryCommonSharesToTheCompanyNetIssuanceCostsValue
67728000
CY2023 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
670000
CY2023 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
87500000
CY2023 roiv Noncontrolling Interest Increase Decrease From Deconsolidation
NoncontrollingInterestIncreaseDecreaseFromDeconsolidation
292000
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
316000
CY2023 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
217781000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1490000
CY2023 us-gaap Profit Loss
ProfitLoss
-1115463000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1607587000
CY2024 roiv Stock Issued During Period Value Net Issuance Costs
StockIssuedDuringPeriodValueNetIssuanceCosts
199822000
CY2024 roiv Stock Issued During Period Value In Connection With Equity Incentive Plans Net Of Forfeitures And Tax Withholding Payments
StockIssuedDuringPeriodValueInConnectionWithEquityIncentivePlansNetOfForfeituresAndTaxWithholdingPayments
-10857000
CY2024 roiv Stock Issued During Period Value Common Share Related To Settlement Of Warrants Value
StockIssuedDuringPeriodValueCommonShareRelatedToSettlementOfWarrantsValue
83264000
CY2024 roiv Stock Issued During Period Value Common Shares Related To Settlement Of Transaction Consideration
StockIssuedDuringPeriodValueCommonSharesRelatedToSettlementOfTransactionConsideration
0
CY2024 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
951000
CY2024 roiv Issuance Of Subsidiary Common Shares To The Company Net Issuance Costs Value
IssuanceOfSubsidiaryCommonSharesToTheCompanyNetIssuanceCostsValue
238733000
CY2024 roiv Stock Issued During Period Value Subsidiary Stock Options Exercised
StockIssuedDuringPeriodValueSubsidiaryStockOptionsExercised
5742000
CY2024 roiv Issuance Of Subsidiary Common Shares To The Company And Capital Contributions To Subsidiaries
IssuanceOfSubsidiaryCommonSharesToTheCompanyAndCapitalContributionsToSubsidiaries
0
CY2024 roiv Noncontrolling Interest Increase Decrease From Deconsolidation
NoncontrollingInterestIncreaseDecreaseFromDeconsolidation
35148000
CY2024 roiv Dividend Declared By Subsidiary
DividendDeclaredBySubsidiary
6000000
CY2024 roiv Noncontrolling Interest Increase Decrease From Disposition
NoncontrollingInterestIncreaseDecreaseFromDisposition
87500000
CY2024 roiv Apic And Noncontrolling Interest Share Based Payment Arrangement Increase For Cost Recognition
APICAndNoncontrollingInterestShareBasedPaymentArrangementIncreaseForCostRecognition
199951000
CY2024 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-936000
CY2024 us-gaap Profit Loss
ProfitLoss
4231206000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6448529000
CY2024 us-gaap Profit Loss
ProfitLoss
4231206000
CY2023 us-gaap Profit Loss
ProfitLoss
-1115463000
CY2024 roiv Non Cash Acquired In Process Research And Development
NonCashAcquiredInProcessResearchAndDevelopment
0
CY2023 roiv Non Cash Acquired In Process Research And Development
NonCashAcquiredInProcessResearchAndDevelopment
87749000
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
199627000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
217781000
CY2024 us-gaap Gain Loss On Investments
GainLossOnInvestments
-47973000
CY2023 us-gaap Gain Loss On Investments
GainLossOnInvestments
-20815000
CY2024 roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-78943000
CY2023 roiv Gain Loss On Fair Value Of Debt And Liability Instruments
GainLossOnFairValueOfDebtAndLiabilityInstruments
-78001000
CY2024 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
32772000
CY2023 us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
29276000
CY2024 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
5348410000
CY2023 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
CY2024 roiv Gain Loss On Recovery Of Contingent Consideration Discontinued Operations
GainLossOnRecoveryOfContingentConsiderationDiscontinuedOperations
0
CY2023 roiv Gain Loss On Recovery Of Contingent Consideration Discontinued Operations
GainLossOnRecoveryOfContingentConsiderationDiscontinuedOperations
114561000
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22036000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18857000
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
6845000
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
7565000
CY2024 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-10249000
CY2023 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
21206000
CY2024 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
81478000
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
31670000
CY2024 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-16488000
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
17416000
CY2024 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
22684000
CY2023 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
4359000
CY2024 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40150000
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
38956000
CY2024 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8326000
CY2023 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-8604000
CY2024 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
21977000
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
18571000
CY2024 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
7540000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2149000
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-765268000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-843393000
CY2024 roiv Proceeds From Sale Of Assets
ProceedsFromSaleOfAssets
5233396000
CY2023 roiv Proceeds From Sale Of Assets
ProceedsFromSaleOfAssets
0
CY2024 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
47500000
CY2023 us-gaap Proceeds From Divestiture Of Interest In Consolidated Subsidiaries
ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries
0
CY2024 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
84483000
CY2023 us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
6706000
CY2024 roiv Proceeds From Sale Of Top Up Shares Discontinued Operations
ProceedsFromSaleOfTopUpSharesDiscontinuedOperations
0
CY2023 roiv Proceeds From Sale Of Top Up Shares Discontinued Operations
ProceedsFromSaleOfTopUpSharesDiscontinuedOperations
114561000
CY2024 roiv Milestone Payments
MilestonePayments
0
CY2023 roiv Milestone Payments
MilestonePayments
140136000
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1382000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12690000
CY2024 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-8592000
CY2023 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-702000
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5203623000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44269000
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
199822000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
311981000
CY2024 roiv Proceeds From Issuance Of Subsidiary Common Shares Net
ProceedsFromIssuanceOfSubsidiaryCommonSharesNet
238733000
CY2023 roiv Proceeds From Issuance Of Subsidiary Common Shares Net
ProceedsFromIssuanceOfSubsidiaryCommonSharesNet
67727000
CY2024 roiv Proceeds From Subsidiary Debt Financings Net
ProceedsFromSubsidiaryDebtFinancingsNet
0
CY2023 roiv Proceeds From Subsidiary Debt Financings Net
ProceedsFromSubsidiaryDebtFinancingsNet
159899000
CY2024 roiv Payments Of Subsidiary Dividends
PaymentsOfSubsidiaryDividends
6000000
CY2023 roiv Payments Of Subsidiary Dividends
PaymentsOfSubsidiaryDividends
0
CY2024 roiv Repayment Of Long Term Debt And Convertible Debt By Subsidiary
RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary
29158000
CY2023 roiv Repayment Of Long Term Debt And Convertible Debt By Subsidiary
RepaymentOfLongTermDebtAndConvertibleDebtBySubsidiary
29452000
CY2024 roiv Payment For Offering And Loan Costs
PaymentForOfferingAndLoanCosts
0
CY2023 roiv Payment For Offering And Loan Costs
PaymentForOfferingAndLoanCosts
2250000
CY2024 roiv Payments Of Taxes For The Repurchase Of Equity
PaymentsOfTaxesForTheRepurchaseOfEquity
37715000
CY2023 roiv Payments Of Taxes For The Repurchase Of Equity
PaymentsOfTaxesForTheRepurchaseOfEquity
10881000
CY2024 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
54314000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2814000
CY2024 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1547000
CY2023 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
692000
CY2024 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
951000
CY2023 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
316000
CY2024 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5000
CY2023 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0
CY2024 roiv Payment For Warrant Redemptions
PaymentForWarrantRedemptions
41000
CY2023 roiv Payment For Warrant Redemptions
PaymentForWarrantRedemptions
0
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
419364000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
499462000
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
616000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6281000
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4858335000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-381919000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1692115000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2074034000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6550450000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1692115000
CY2024 roiv Cashless Exercise Of The Company Common Stock Warrants
CashlessExerciseOfTheCompanyCommonStockWarrants
83258000
CY2023 roiv Cashless Exercise Of The Company Common Stock Warrants
CashlessExerciseOfTheCompanyCommonStockWarrants
0
CY2024 roiv Common Shares And Other Consideration Issued For Purchase Of Property And Equipment
CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment
0
CY2023 roiv Common Shares And Other Consideration Issued For Purchase Of Property And Equipment
CommonSharesAndOtherConsiderationIssuedForPurchaseOfPropertyAndEquipment
9694000
CY2024 roiv Noncash Other
NoncashOther
2231000
CY2023 roiv Noncash Other
NoncashOther
10860000
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12354000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5128000
CY2024 us-gaap Interest Paid Net
InterestPaidNet
10268000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
5303000
CY2024 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6500000000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
576200000
CY2024 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4200000000
CY2023 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1200000000
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<div style="color: rgb(33, 37, 41); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(B) Use of Estimates</div> <div style="color: rgb(33, 37, 41); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-family: 'Times New Roman';"><br/> </span> </div> <div style="display:none;"><br/></div> <div style="color: rgb(33, 37, 41); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt; text-align: justify;"><span style="font-family: 'Times New Roman';">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company regularly evaluates estimates and assumptions related to assets, liabilities, costs, expenses, contingent liabilities, share-based compensation and research and development costs. The Company bases its estimates and assumptions on historical experience and on various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates. </span> </div>
CY2024 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="color: rgb(33, 37, 41); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;">(C) Concentrations</div> <div style="color: rgb(33, 37, 41); font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-family: 'Times New Roman';"><br/> </span> </div> <div style="display:none;"><br/></div> <div style="color: rgb(33, 37, 41); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt; text-align: justify;">Financial instruments that potentially subject the Company to concentration of credit risk include cash and cash equivalents. The Company maintains cash deposits and cash equivalents in highly-rated, federally-insured financial institutions in excess of federally insured limits. The Company has established guidelines relative to diversification and maturities to maintain safety and liquidity. The Company has not experienced any credit losses related to these financial instruments and does not believe that it is exposed to any significant credit risk related to these instruments.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(33, 37, 41); font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"><br/> </span> </div> <div style="display:none;"><br/></div> <div style="color: rgb(33, 37, 41); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 27pt; text-align: justify;">The Company has long-lived assets in different geographic locations. As of March 31, 2024 and 2023, a majority of the Company’s long-lived assets were located in the United States (“U.S.”).</div>
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6535706000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1676813000
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
5367000
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
5011000
CY2024Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
9377000
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
10291000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6550450000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1692115000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
61242000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
55186000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
155171000
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
152629000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
17329000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7748000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
137842000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
144881000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
9500000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
9500000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9500000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9500000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
9500000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
90300000
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
55096000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
60827000
CY2024Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
53545000
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
30379000
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
5367000
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
5011000
CY2024Q1 us-gaap Inventory Net
InventoryNet
35251000
CY2023Q1 us-gaap Inventory Net
InventoryNet
2761000
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1827000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2356000
CY2024Q1 us-gaap Interest Receivable
InterestReceivable
27441000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
4909000
CY2024Q1 roiv Other Of Other Assets Current
OtherOfOtherAssetsCurrent
17595000
CY2023Q1 roiv Other Of Other Assets Current
OtherOfOtherAssetsCurrent
15531000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
196122000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
121774000
CY2024Q1 roiv Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
40313000
CY2023Q1 roiv Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
76278000
CY2024Q1 roiv Accrued Sales Allowances Current
AccruedSalesAllowancesCurrent
23277000
CY2023Q1 roiv Accrued Sales Allowances Current
AccruedSalesAllowancesCurrent
17569000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
50754000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18096000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
175586000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
167129000
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4168000
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
12444000
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
10469000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
542000
CY2024Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1417000
CY2023Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
2090000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
16054000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15076000
CY2024 roiv Number Of Equity Incentive Plans
NumberOfEquityIncentivePlans
3
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4253430000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1224834000
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
22224000
CY2024 roiv Share Based Payment Arrangement Award Modification Expense
ShareBasedPaymentArrangementAwardModificationExpense
20800000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5190000
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22224000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5190000
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0
CY2024 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
0
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2024 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1155668000
CY2024 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.2717
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-208440000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.1702
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
0
CY2024 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Research And Development
IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
17714000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.0145
CY2024 roiv Effective Income Tax Rate Reconciliation Nondeductible Nontaxable Changes In Fair Value Of Investments And Loss From Equity Method Investment
EffectiveIncomeTaxRateReconciliationNondeductibleNontaxableChangesInFairValueOfInvestmentsAndLossFromEquityMethodInvestment
15431000
CY2024 roiv Effective Income Tax Rate Reconciliation Nondeductible Nontaxable Changes In Fair Value Of Investments And Loss From Equity Method Investment Percent
EffectiveIncomeTaxRateReconciliationNondeductibleNontaxableChangesInFairValueOfInvestmentsAndLossFromEquityMethodInvestmentPercent
0.0036
CY2023 roiv Effective Income Tax Rate Reconciliation Nondeductible Nontaxable Changes In Fair Value Of Investments And Loss From Equity Method Investment
EffectiveIncomeTaxRateReconciliationNondeductibleNontaxableChangesInFairValueOfInvestmentsAndLossFromEquityMethodInvestment
4118000
CY2023 roiv Effective Income Tax Rate Reconciliation Nondeductible Nontaxable Changes In Fair Value Of Investments And Loss From Equity Method Investment Percent
EffectiveIncomeTaxRateReconciliationNondeductibleNontaxableChangesInFairValueOfInvestmentsAndLossFromEquityMethodInvestmentPercent
-0.0034
CY2024 roiv Effective Income Tax Rate Reconciliation Substantial Shareholding Exemption Amount
EffectiveIncomeTaxRateReconciliationSubstantialShareholdingExemptionAmount
-1337102000
CY2024 roiv Effective Income Tax Rate Reconciliation Significant Shareholding Exemption Percent
EffectiveIncomeTaxRateReconciliationSignificantShareholdingExemptionPercent
-0.3144
CY2023 roiv Effective Income Tax Rate Reconciliation Substantial Shareholding Exemption Amount
EffectiveIncomeTaxRateReconciliationSubstantialShareholdingExemptionAmount
0
CY2023 roiv Effective Income Tax Rate Reconciliation Significant Shareholding Exemption Percent
EffectiveIncomeTaxRateReconciliationSignificantShareholdingExemptionPercent
0
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
19727000
CY2024 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0046
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
20558000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.0168
CY2024 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-21668000
CY2024 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.0051
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
3311000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.0027
CY2024 roiv Effective Income Tax Rate Reconciliation Permanent Adjustments Amount
EffectiveIncomeTaxRateReconciliationPermanentAdjustmentsAmount
40544000
CY2024 roiv Effective Income Tax Rate Reconciliation Other Permanent Adjustments Percent
EffectiveIncomeTaxRateReconciliationOtherPermanentAdjustmentsPercent
0.0095
CY2023 roiv Effective Income Tax Rate Reconciliation Permanent Adjustments Amount
EffectiveIncomeTaxRateReconciliationPermanentAdjustmentsAmount
10936000
CY2023 roiv Effective Income Tax Rate Reconciliation Other Permanent Adjustments Percent
EffectiveIncomeTaxRateReconciliationOtherPermanentAdjustmentsPercent
-0.0089
CY2024 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
24664000
CY2024 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0058
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
14487000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.0118
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
87550000
CY2024 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.0206
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
157197000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.1283
CY2024 roiv Effective Income Tax Rate Reconciliation Reversal Of Certain Deferred Tax Assets Amount
EffectiveIncomeTaxRateReconciliationReversalOfCertainDeferredTaxAssetsAmount
87262000
CY2024 roiv Effective Income Tax Rate Reconciliation Reversal Of Certain Deferred Tax Assets Percent
EffectiveIncomeTaxRateReconciliationReversalOfCertainDeferredTaxAssetsPercent
0.0206
CY2023 roiv Effective Income Tax Rate Reconciliation Reversal Of Certain Deferred Tax Assets Amount
EffectiveIncomeTaxRateReconciliationReversalOfCertainDeferredTaxAssetsAmount
11630000
CY2023 roiv Effective Income Tax Rate Reconciliation Reversal Of Certain Deferred Tax Assets Percent
EffectiveIncomeTaxRateReconciliationReversalOfCertainDeferredTaxAssetsPercent
-0.0095
CY2024 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-524000
CY2024 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0001
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
2653000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.0021
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22224000
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0052
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5190000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0042
CY2024 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0052
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0042
CY2024Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
45291000
CY2023Q1 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
37559000
CY2024Q1 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
50054000
CY2023Q1 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
52857000
CY2024Q1 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
32124000
CY2023Q1 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
37252000
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
519046000
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
422613000
CY2024Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
105458000
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
105343000
CY2024Q1 roiv Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
13286000
CY2023Q1 roiv Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
15521000
CY2024Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
19605000
CY2023Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
25959000
CY2024Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
784864000
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
697104000
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
766820000
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
674517000
CY2024Q1 roiv Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
775000
CY2023Q1 roiv Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
1798000
CY2024Q1 roiv Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
10992000
CY2023Q1 roiv Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
12959000
CY2024Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
6277000
CY2023Q1 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
7830000
CY2024Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2023Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
766800000
CY2024 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
92300000
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2024Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2024 us-gaap Operating Lease Cost
OperatingLeaseCost
11829000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
12045000
CY2024 us-gaap Short Term Lease Cost
ShortTermLeaseCost
79000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1623000
CY2024 us-gaap Variable Lease Cost
VariableLeaseCost
1193000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
2151000
CY2024 roiv Operating Lease Costs
OperatingLeaseCosts
13101000
CY2023 roiv Operating Lease Costs
OperatingLeaseCosts
15819000
CY2024 us-gaap Operating Lease Payments
OperatingLeasePayments
13010000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
13109000
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1790000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4224000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y9M18D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y4M24D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.074
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10699000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9657000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8852000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8867000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
8747000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
28565000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
75387000
CY2024Q1 roiv Operating Lease Liability Present Value Adjustments
OperatingLeaseLiabilityPresentValueAdjustments
17843000
CY2024Q1 roiv Lessee Operating Lease Liability Tenant Improvement Allowance
LesseeOperatingLeaseLiabilityTenantImprovementAllowance
386000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
57158000
CY2023Q2 roiv Cashless Public Warrant Exercised
CashlessPublicWarrantExercised
20061507
CY2023Q2 roiv Class Of Warrant Or Right Unexercised Price Of Warrants
ClassOfWarrantOrRightUnexercisedPriceOfWarrants
413971
CY2023Q2 roiv Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.1
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001140361-24-028145-index-headers.html Edgar Link pending
0001140361-24-028145-index.html Edgar Link pending
0001140361-24-028145.txt Edgar Link pending
0001140361-24-028145-xbrl.zip Edgar Link pending
ef20026301_10k.htm Edgar Link pending
ef20026301_ex21-1.htm Edgar Link pending
ef20026301_ex23-1.htm Edgar Link pending
ef20026301_ex31-1.htm Edgar Link pending
ef20026301_ex31-2.htm Edgar Link pending
ef20026301_ex32-1.htm Edgar Link pending
ef20026301_ex32-2.htm Edgar Link pending
ef20026301_ex97.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image01.jpg Edgar Link pending
image02.jpg Edgar Link pending
image03.jpg Edgar Link pending
image04.jpg Edgar Link pending
image05.jpg Edgar Link pending
ef20026301_10k_htm.xml Edgar Link completed
image06.jpg Edgar Link pending
image07.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
roiv-20240331.xsd Edgar Link pending
Show.js Edgar Link pending
roiv-20240331_lab.xml Edgar Link unprocessable
roiv-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
roiv-20240331_cal.xml Edgar Link unprocessable
roiv-20240331_def.xml Edgar Link unprocessable